%0 Journal Article
%T Breast cancer patients with lobular cancer more commonly have a father than a mother diagnosed with cancer
%A Carolina Ellberg
%A H£¿kan Olsson
%J BMC Cancer
%D 2011
%I BioMed Central
%R 10.1186/1471-2407-11-497
%X In 1676 consecutive breast cancer patients detailed family history of cancer was related to histopathologic subtype of breast cancer.Patients with lobular breast cancer were found to be significantly positively associated with having a father diagnosed with cancer, OR 2.17 (95% confidence interval (CI) 1.37-3.46). The finding persisted after excluding breast cancer in the family. Ductal breast cancer was associated with having a mother diagnosed with cancer. There was a significant association between lobular breast cancer and having a father with prostate cancer, OR 2.4 (CI 1.1-5.3). The occurrence of having a father with prostate cancer for lobular breast cancer patients was higher in the younger patient group, OR 2.9 (CI 1.1-7.8), and was still high but lost statistical significance in the older patient group, OR 1.9 (CI 0.5-7.4). The association between lobular breast cancer and a father remained significant after excluding fathers with prostate cancer, OR 1.94 (CI 1.20-3.14). Other commonly occurring tumor types in the father included sarcoma and leukemia.We propose that lobular breast cancer is associated with having a father diagnosed with cancer, most commonly prostate carcinoma. Since the association remained after excluding family history of breast cancer, the association seems independent of classical breast cancer heredity. The association with a father diagnosed with cancer also remained after removing prostate cancer, indicating an independence from prostate cancer as well. The reason for this association is genetically unclear, but could involve sex-specific imprinting.Risk factors, both genetic and environmental differ between the histopathological subtypes of breast cancer, one example is parity. It has been shown that increased parity reduced the risk for all subtypes with the exception of medullary breast cancer [1]. Another risk factor, ever-use of HRT is associated with an increased risk of lobular breast cancer [2]. In hereditary breast cancer,
%U http://www.biomedcentral.com/1471-2407/11/497